The application of tissue microarrays to cancer research

被引：35
作者：
Horvath, L [1 ]
Henshall, S [1 ]
机构：
[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
来源：
PATHOLOGY | 2001年 / 33卷 / 02期
关键词：
cancer; tissue microarray; in situ hybridisation; immunohistochemistry; revieW;
D O I：
10.1080/003130201200338791
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Tissue microarrays are paraffin blocks containing multiple cyclindrical tissue biopsy cores taken from individual donor paraffin-embedded tissue blocks and placed into a recipient block with defined array coordinates. Tissue microarray technology facilitates rapid assessment of the clinical relevance of molecular markers by enabling the simultaneous analysis of hundreds of tissue specimens. One of the applications of this technology is to significantly accelerate advances in cancer research through more efficient assessment of novel markers of outcome and response and, as a result, a more rapid application of this knowledge to clinical practice.
引用
收藏
页码：125 / 129
页数：5
相关论文
共 17 条
  • [1] Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis
    Bärlund, M
    Forozan, F
    Kononen, J
    Bubendorf, L
    Chen, YD
    Bittner, ML
    Torhorst, J
    Haas, P
    Bucher, C
    Sauter, G
    Kallioniemi, OP
    Kallioniemi, A
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15) : 1252 - 1259
  • [2] Hormone therapy failure in human prostate cancer:: Analysis by complementary DNA and issue microarrays
    Bubendorf, L
    Kolmer, M
    Kononen, J
    Koivisto, P
    Mousses, S
    Chen, YD
    Mahlamäki, E
    Schraml, P
    Moch, H
    Willi, N
    Elkahloun, AG
    Pretlow, TG
    Gasser, TC
    Mihatsch, MJ
    Sauter, G
    Kallioniemi, OP
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (20) : 1758 - 1764
  • [3] Bubendorf L, 1999, CANCER RES, V59, P803
  • [4] Coates A, 1998, RECENT RES CANCER, V152, P429
  • [5] Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
    Colleoni, M
    Bonetti, M
    Coates, AS
    Castiglione-Gertsch, M
    Gelber, RD
    Price, K
    Rudenstam, CM
    Lindtner, J
    Collins, J
    Thürlimann, B
    Holmberg, S
    Veronesi, A
    Marini, G
    Goldhirsch, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 584 - 590
  • [6] DeRisi J, 1996, NAT GENET, V14, P457
  • [7] p53 status and prognosis of locally advanced prostatic adenocarcinoma: A study based on RTOG 8610
    Grignon, DJ
    Caplan, R
    Sarkar, FH
    Lawton, CA
    Hammond, EH
    Pilepich, MV
    Forman, JD
    Mesic, J
    Fu, KK
    Abrams, RA
    Pajak, TF
    Shipley, WU
    Cox, JD
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (02): : 158 - 165
  • [8] Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
    Kattan, MW
    Wheeler, TM
    Scardino, PT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1499 - 1507
  • [9] Tissue microarrays for high-throughput molecular profiling of tumor specimens
    Kononen, J
    Bubendorf, L
    Kallioniemi, A
    Bärlund, M
    Schraml, P
    Leighton, S
    Torhorst, J
    Mihatsch, MJ
    Sauter, G
    Kallioniemi, OP
    [J]. NATURE MEDICINE, 1998, 4 (07) : 844 - 847
  • [10] High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
    Moch, H
    Schraml, P
    Bubendorf, L
    Mirlacher, M
    Kononen, J
    Gasser, T
    Mihatsch, MJ
    Kallioniemi, OP
    Sauter, G
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) : 981 - 986
12